4Filed Aug 3, 8:00 PM ET

Imunon (IMNN) Exec Chairman Michael H. Tardugno Receives Award

$IMNN · Imunon, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Imunon (IMNN) Exec Chairman Michael H. Tardugno Receives Award

What Happened Michael H. Tardugno, Executive Chairman of the Board and a director of Imunon, Inc. (IMNN), was granted 6,358 shares on July 31, 2026. The shares were recorded at $1.59 per share, for a total reported value of $10,109. This transaction is an award/grant (transaction code A) — stock issued as compensation rather than an open‑market purchase or sale.

Key Details

  • Transaction date: July 31, 2026; grant price reported: $1.59 per share.
  • Shares granted: 6,358; total reported value: $10,109.
  • Transaction type/code: A (award/grant).
  • Footnote: Shares were granted in lieu of cash for base salary.
  • Filing date (Form 4): August 4, 2026 (transaction date was July 31, 2026). The filing shows the grant; verify SEC EDGAR if you need confirmation on timeliness.
  • Shares owned after the transaction: not specified in the provided filing.

Context Grants made in lieu of cash for salary are a common form of executive compensation and are generally considered routine — they do not necessarily signal a personal market view. For retail investors, purchases or open‑market buys tend to be more informative about insider sentiment than routine compensation grants.